about
Approved Antiviral Drugs over the Past 50 YearsAssessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field studyLow Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern MalawiThe diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs.Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.What's wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.Interplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.Risk assessment for antibiotic resistance in South East AsiaIn vitro Comparison of Generic and Branded Preparations of Amoxicillin with Potassium Clavulanate.Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.Analysis of low molecular weight compounds using MALDI- and LDI-TOF-MS: Direct detection of active pharmaceutical ingredients in different formulations.A current perspective on antimicrobial resistance in Southeast Asia.Diagnostic Accuracy of Global Pharma Health Fund Minilab™ in Assessing Pharmacopoeial Quality of Antimicrobials.Amoxicillin Quality and Selling Practices in Urban Pharmacies and Drug Stores of Blantyre, Malawi.Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries.
P2860
Q27755387-2909337D-655C-4C5E-AEDF-CC6E0F4DB495Q28647142-BF0F04E7-35DB-44FE-BC0C-BC635336FA95Q30377168-E4975377-52A9-4B38-BF17-95BDF59EB16FQ36686951-F12E6D3F-AE68-456B-B9D5-2B174460F8F5Q37736858-4E87B751-F5CE-4B97-8F68-4DC6B0416735Q38975846-442AD8D0-1AA5-4E7C-BE35-AE9907FA5E35Q40040578-1B634146-D5B6-468D-9185-FE78317F1D8DQ40067159-C185919C-D8E3-41B1-8694-1F8988783696Q41100487-0B3E83DE-4BE6-4FCC-9494-AB2BED3111AFQ41514472-00437F16-581D-4EE2-B94A-28589551ECD3Q41634918-1681B3F9-7747-4637-8AAA-1B12B27A2592Q47194322-3DA05FB1-F02F-4E06-938F-0A7D2A0B6E3CQ48583050-833C93FC-55C8-43DA-A665-9EC5DC433715Q49989837-EA1A846C-4B7C-4335-8521-59CDDD2F263DQ53689663-F403C01C-37B7-4A9A-8578-06B4CA955FB0Q55035189-C02A0AD4-4E5F-4109-BEE6-9A5FD4F11941
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Substandard/counterfeit antimicrobial drugs
@ast
Substandard/counterfeit antimicrobial drugs
@en
Substandard/counterfeit antimicrobial drugs
@nl
type
label
Substandard/counterfeit antimicrobial drugs
@ast
Substandard/counterfeit antimicrobial drugs
@en
Substandard/counterfeit antimicrobial drugs
@nl
prefLabel
Substandard/counterfeit antimicrobial drugs
@ast
Substandard/counterfeit antimicrobial drugs
@en
Substandard/counterfeit antimicrobial drugs
@nl
P2860
P356
P1476
Substandard/counterfeit antimicrobial drugs
@en
P2860
P304
P356
10.1128/CMR.00072-14
P407
P577
2015-04-01T00:00:00Z